In the last Oncopeptalks episode of the year, David and Sofia summarizes the eventful 2024. They cover topics such as the future of Oncopeptides in the U.S., Spain and Italy, licensing agreements, financials and sales development.
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
